- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02371239
SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2 (SIT LESS 2)
Introduction: Changes in lifestyle are responsible for an important part of the type 2 diabetes epidemic of the last decennia. Current guidelines for physical activity focus mainly on high energy expenditure advising 30 minutes per day moderate to vigorous physical activity (most often physical exercise). Recent studies suggest that sitting has negative metabolic effects independent of the time spent exercising (Duvivier et al. PLOS ONE 2013).
Low intensity physical activity (LIPA) -such as walking and standing- has been suggested to be an alternative to decrease the hyperglycaemic effect of sitting. Compared to exercise, LIPA might be a more feasible strategy. But, it remains to be determined whether reducing sitting time by replacing it by LIPA, results in lower 24 hour blood glucose levels and less blood glucose fluctuations (glycaemic variability) in type 2 diabetes patients and whether these effects are independent of the increase in energy expenditure
Methods: The study population will involve 19 people with type 2 diabetes (BMI: 25-35 kg/m2) who perform no, or only little, exercise and who are treated with diet only or with oral blood glucose lowering medication. They will perform three regimes of each four days: 1) a sitting regime, 2) an exercise regime and a 3) sit less regime. Daily energy expenditure of the exercise regime will be identical to that of the sit less regime. Sitting, walking and standing will be objectively measured by a 24 hour physical activity monitor. The energy spent during exercise will be standardised and quantified by using a bicycle ergometer; energy intake will be standardised as well. During each regime blood glucose will be measured with a 24 hour continuous glucose sensor.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Limburg
-
Maastricht, Limburg, Holandia, 6200 MD
- Human Movement Science, Maastricht University
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Signed informed consent
- Men and women: 40-75 years old
- Diabetes mellitus type 2, developed after the age of 40 years old
- Treatment with diet or oral blood glucose lowering medication (metformin and/or SU-derivatives and/or DPP-IV inhibitors)
- HbA1c: < 10%
- BMI: 25.0 - 35.0 kg/m2
- Maximum 2.5 hours of MVPA per week (during last 3 months)
- Internet availability on a daily basis
Exclusion Criteria:
- Pregnancy or intention of becoming pregnant
- Alcohol use: > 2 units per day (during the last 3 months)
- Experimental drug use (during the last 3 months)
- Use of insulin, corticosteroids, vitamin K antagonists and immunosuppressive drugs in the last 3 months
- Triglyceride level > 10.0 mmol/L
- Fasting plasma glucose level > 10 mmol/L
- Heart failure NYHA 3 or higher
- Angina pectoris or signs of cardiac ischemia during exercise testing
- COPD Gold 3 or higher
- Glomerular filtration rate (GFR) < 30 ml/min
- Diagnosis of active cancer (not cancer in the past that is cured)
- Diabetes mellitus type 1
- Intermittent claudication with a walking distance < 500 meter
- Not able to cycle for ± 45 minutes, as judged from the incremental exhaustive exercise bicycle-ergometer test at Visit 1
- Based on historical information not able to walk for 3 hours per day and stand for 4 hours per day
- Mental or physical disability which makes physical activity not possible
- Participation in a clinical trial with medication use (in the last 3 months)
- Severe loss of vision
- Active foot ulcer or venous leg ulcer
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Zadanie krzyżowe
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Sitting regime
The subjects will follow the sitting regime during four days.
Each day: 14 hours sitting, 1 hour walking and 1 hour standing for daily care and 8 hours sleeping or lying.
|
|
|
Eksperymentalny: Sit Less regime
Subjects will follow the sit less regime during four days.
Each day will consist of 3 hours walking, 4 hours standing, 9 hours sitting and 8 hours sleeping or lying.
The additional 2 hours of walking and 3 hours of standing, compared to the sitting regime, will be done in a minimum of four bouts with a time interval of > 1 hour.
The subjects will be instructed to walk on a slow pace.
i.e. 2-3 km/h, which is comparable to walking during shopping, walking to the office etc.
|
|
|
Eksperymentalny: Exercise regime
Subjects will follow the exercise regime during four days.
Each day will consist of 13 hours and 15 minutes sitting, ± 45 minutes supervised cycling on an ergometer, 1 hour walking and 1 hour standing for daily care and 8 hours sleeping or lying.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Ramy czasowe |
|---|---|
|
Mean 24 hour glucose concentration
Ramy czasowe: during the last 24 hours of an activity regime
|
during the last 24 hours of an activity regime
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Total duration (minutes) of hyperglycaemia (glucose > 10 mmol/L)
Ramy czasowe: during the last 24 hours of an activity regime
|
during the last 24 hours of an activity regime
|
|
|
Mean 24 hour glucose concentration
Ramy czasowe: during a whole activity regime
|
during a whole activity regime
|
|
|
Total duration of hyperglycaemia (glucose > 10 mmol/L)
Ramy czasowe: during a whole activity regime
|
during a whole activity regime
|
|
|
Area under the curve of hyperglycaemia (glucose > 10 mmol/L)
Ramy czasowe: during the last 24 hours of an activity regime
|
during the last 24 hours of an activity regime
|
|
|
Glucose variability measured as SD divided by mean
Ramy czasowe: the last 24 hours of each regime
|
the last 24 hours of each regime
|
|
|
Total duration of hypoglycaemia (glucose ≤ 3.9 mmol/L)
Ramy czasowe: during a whole activity regime
|
during a whole activity regime
|
|
|
Fasting total cholesterol
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Non-HDL cholesterol
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
HDL cholesterol
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
LDL cholesterol
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Triglycerides
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Apolipoprotein B
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Apolipoprotein A
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Free fatty acids
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Fasting glucose
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Fasting insulin
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Fasting C-peptide
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Fasting CRP
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Fasting IL-6
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Fasting IL-1
Ramy czasowe: one day after each activity regime
|
one day after each activity regime
|
|
|
Homeostatic model assessment 2 (HOMA2)
Ramy czasowe: one day after each activity regime
|
to assess insulin sensitivity
|
one day after each activity regime
|
Współpracownicy i badacze
Współpracownicy
Śledczy
- Główny śledczy: Nicolaas C Schaper, MD PhD, Maastricht University Hospital
Publikacje i pomocne linki
Publikacje ogólne
- Duvivier BM, Schaper NC, Bremers MA, van Crombrugge G, Menheere PP, Kars M, Savelberg HH. Minimal intensity physical activity (standing and walking) of longer duration improves insulin action and plasma lipids more than shorter periods of moderate to vigorous exercise (cycling) in sedentary subjects when energy expenditure is comparable. PLoS One. 2013;8(2):e55542. doi: 10.1371/journal.pone.0055542. Epub 2013 Feb 13. Erratum In: PLoS One. 2014;9(8):e105135.
- Duvivier BM, Schaper NC, Hesselink MK, van Kan L, Stienen N, Winkens B, Koster A, Savelberg HH. Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes. Diabetologia. 2017 Mar;60(3):490-498. doi: 10.1007/s00125-016-4161-7. Epub 2016 Nov 30.
Przydatne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 13-2-050
- NL45498.068.13 (Identyfikator rejestru: Medical Ethical Committee Maastricht University Hospital / University of Maastricht)
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
produkt wyprodukowany i wyeksportowany z USA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .